History of Pioneers - Diabetes testing

The Development of Hemoglobin A1c (HbA1c) fractionation quantitative analyzer

The world first Hemoglogin A1c analyzer (AUTO A1c)
The world first Hemoglogin
A1c analyzer (AUTO A1c)

In the summer of 1979, a development theme for a new instrument was determined, and a team of 6 - 7 engineers of machines, electronics, and software was organized. The theme was to develop a testing instrument using hemoglobin A1c (HbA1c) analytical column, which was a collaborative project of Sekisui Chemical Co., Ltd Central Research Institute and Osaka City University Medical School. In those days, it was not practical to measure HbA1c because the hemoglobin analyzer was too expensive and difficult to use, and it took as long as 24 hours for measuring. The goal for the development team was producing a single-analyte hemoglobin analyzer which could be operated even by a lay user on a daily basis.

Hemoglobin A1c and High Performance Liquid Chromatography (HPLC) Method

HbA1c, a type of glycated protein, is a binding of hemoglobin (protein) and glucose (sugar). HbA1c accounts for about 4 to 15 % of total hemoglobin. Since HbA1c represents the average blood glucose level of the past 2 months, it is an indispensable test item for diabetes diagnosis and care.

Measuring HbA1c requires fractionating hemoglobin into various different types of hemoglobin for quantification where the proportion of the different hemoglobin is calculated. Liquid Chromatography (LC) method was typically used for this.

Mikhail S. Tswett 
(1872-1919)
Mikhail S. Tswett
(1872-1919)

Liquid chromatography has a long history. It is said that it was originated in a discovery by a Russian botanist. The Russian botanist Mikhail S. Tswett (1872-1919) found that pigment composition became separated when plant pigment (chlorophyll) together with petroleum ether went through calcium carbonate layer. High Performance Liquid Chromatography (HPLC), which is faster liquid chromatography, is now the necessity in separation analysis.

When the new analyzer was being developed, HPLC instruments were on the market as general-purpose instruments. However, they were used only in university laboratories, professional analysis companies, and some test institutions, because they were huge and complicated system that required expert operators to keep stable use condition. In addition, even small changes in flow volume, pressure, temperature, and chromatography column would cause a big difference in the test result, so that people believed that HPLC was not suitable for quantitative analysis in clinical settings.
Under the situation, our company's engineers worked hard on what would make it possible to bring in HPLC to clinical fields.
They came to the conclusion that the key was the performance stability and the price of the system. In HPLC, the solution sending pressure sometimes goes up to 50Kg/cm2 or more (the same pressure you get in 500m water depth), so the new analyzer needed many unusual components that were most unlikely in ordinary automatic biochemical test instrument (such as high-pressure solution sending pump, high-pressure bulb, high-pressure damper etc). If we had bought all of these components, it would have cost us tens of millions of yen. Thus, we decided to make the components in our company, making the best of all the HPLC techniques that had been developed until then. Most of the technical challenges were totally new for our development team -- development of flow cell optical system with small dead volume and good linearity, high-pressure pump with little pulse, high-pressure injection bulb, floating point calculation software with wide dynamic range, control of new microcomputer system, etc. We achieved them one by one, and made high-quality and low-price components, and finally succeeded in developing a HPLC system for high performance at reasonable price that could be accepted by general hospitals and test institutions.
Our company took charge of the development of the instruments and Sekisui Chemical took charge of the development of the chromatography column. Together we gave birth to HA-8110, the world's first HPLC HbA1c fractionation quantitative analyzer.

HA8180T_fs.jpg
The latest model ADAMS A1c HA-8180V

View Products Info

We use (i) Necessary cookies to provide you with services on the website, (ii) Functional cookies to ensure the proper functioning of browsing, (iii) Analytical cookies to collect information to analyze the traffic to the website and (iv) Performance cookies to count visits and traffic sources in order to improve website performance.
You can inhibit Functional cookies and/or both Analytical and Performance cookies by clicking on OPTIONS.
By clicking ACCEPT, it will be deemed that you accept all the mentioned types of cookies.

When you visit our website, we use the following cookies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and accept/decline certain types of cookies that would otherwise be stored on your computer while browsing our website by adding/removing check marks. But keep in mind that deleting cookies may have an impact on your experience with our website.